Dani Bancroft, Author at Labiotech.eu - Page 6 of 23

Subscribe to our newsletter

Subscribe to our newsletter

biotech funding money business oncology neurology

Advertise with us

Podcast Reports

About

Former Editor, now flitting back and forth as a freelancer. Originally from London and studied Zoology at the University of Reading, UK. Previous work includes having written for The Spark University Newspaper and the Wellcome Trust.

Articles by Dani Bancroft

world parkinson parkinsons disease awareness day CNS biotech neurological neurodegenerative

News and Trends 11 Apr 2016

It’s World Parkinson’s Disease Day! #EndParkinsons

Today (April 11th) is the birthday of the memorable Dr James Parkinson, who discovered this major neurodegenerative disease. So what is Parkinson’s Disease, and who is researching it? First described in 1817 by James Parkinson, Parkinson’s Disease (PD) is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer’s. Since PD mainly affects […]

April 11, 2016 - 4 minutesmins - By Dani Bancroft

spix meiogenix bayer crop gene technology crispr food meiotic spo11 recombination biotech agriculture

News and Trends 8 Apr 2016

French Gene Technology and Bayer to ‘Unlock’ Food Crop Diversity

Meiogenix (France) has signed with Bayer Crop Science (Germany) for use of their gene-editing platform, to try and ‘Unlock’ crop genetic diversity and improve food security. Launched in 2011, this Parisian biotech was a spin-off of the Institut Curie and the French Agricultural Agency (INRA) after successfully raised funding. Now, under this non-exclusive agreement, Meiogenix […]

April 8, 2016 - 3 minutesmins - By Dani Bancroft

perkin elmer chemagic dna extraction blood ngs

News and Trends 5 Apr 2016

How can we Optimise DNA Extraction from Human Blood for more Sensitive NGS Analysis?

The increasing relevance of Next Generation Sequencing (NGS) in genetic research means there is a high demand for nucleic acid isolation from human fluids. So how can we perform efficient DNA extraction from human blood? NGS has revolutionised genetic research, by serving as a powerful processing technology, cutting time taken to run genetic analysis and also the cost. […]

April 5, 2016 - 3 minutesmins - By Dani Bancroft

synbiobeta infographic synthetic biology europe industry biotec oxitec investors evolva deinove

News and Trends 28 Mar 2016

Infographic: A Handy Guide to the European Synthetic Biology Startup Scene

The rise of Synthetic biology has radicalised how the biotech industry innovates, develops and invests. Here is an infographic put together by SynBioBeta (the ‘Activity hub for the SynBio industry’). Synbio is now an essential source of research, particularly in the Greentech field. For example, Deinove (France) has signed major partnerships with the US on Synbio […]

March 28, 2016 - 2 minutesmins - By Dani Bancroft

biotech medtech fund endeavour europe

News and Trends 24 Mar 2016

Endeavouring to Establish Europe’s Largest MedTech Fund

The VC Endeavour Vision (Switzerland) has finally closed its Endeavour Medtech Growth (EMG) at €250M. This makes it one of the largest funds dedicated to MedTech innovation worldwide! Largely oversubscribed, the fund reached its hard cap and closed well above its €150M target, finally reaching €250M – the largest fund dedicated to medtech in Europe, and one of the largest pure […]

March 24, 2016 - 2 minutesmins - By Dani Bancroft

bento lab philipp boeing kickstarter diy bio biohacking ucl igem

News and Trends 22 Mar 2016

The ‘Lunch Box’ sized Laboratory for Biohackers, Educators and Artists

Bento Bio is a London SynBio start-up founded around the Bento Lab; designed to include all the major components needed for a field laboratory, but with a sleek (and frankly, very good looking) interface. I met Philipp Boeing at a ‘Digital Biology’ (Do-it-yourself) meet-up in Berlin a couple months back, where the biohacking community would come […]

March 22, 2016 - 7 minutesmins - By Dani Bancroft

ADVERTISEMENT

russia biotech hepatera maxwell mya hepatits b d phase ii b trials

News and Trends 22 Mar 2016

Biotech in Russia: Money and a New trial for Hepatitis

The Biotech MYR Pharma (Germany) is launching German-Russian phase IIb trials for chronic hepatitis B & D infections in partnership with Moscow’s Hepatera (Russia). MYR was founded in 2010 and is based in Burgwedel, Germany, supported by investors Maxwell Biotech and High-Tech Gründerfonds (HTGF). Hepatera, on the other hand, is actually the first Russian biotech we’ve encountered […]

March 22, 2016 - 2 minutesmins - By Dani Bancroft

biotech brexit eu referendum UK expat

News and Trends 15 Mar 2016

How will the UK’s Potential Exit from the EU Affect the Biotech Industry?

I’m a UK Expat in Berlin, and whilst I admit confusion over where exactly the British Exit (i.e. “Brexit”) will leave me in the future, in general it is a depressing thought – for the UK Biotech Industry also. What exactly are the Industry logistics for the UK detaching itself from the EU? Admittedly there […]

March 15, 2016 - 6 minutesmins - By Dani Bancroft

cancer top 8 biotech immunooncology europe oncology

News and Trends 7 Mar 2016

Infographic: The Top 8 Deadliest Cancers and Who in Biotech is Fighting Them

With more than 200 types of cancer, the possibility of developing a Universal Cure is in reality, a myth. However, the fight against the World’s Deadliest Cancers is far from being lost… Simply by having a quick look through our articles, we can easily confirm that cancer is one of the World’s main concerns in […]

March 7, 2016 - 2 minutesmins - By Dani Bancroft

rare disease tops biotech disease

News and Trends 29 Feb 2016

It’s Rare Disease Day 2016: Here are 7 Indications which Biotech is Fighting

According to the European Organisation for Rare Disease, there are 20–30 million people in Europe alone who are affected by one of an estimated 6,000 rare diseases. These include many rare genetic disorders, such as Duchenne’s muscular dystrophy, but also rare forms of cancer and auto-immune disease. The term rare can, therefore, be misleading as many diseases are entering […]

February 29, 2016 - 6 minutesmins - By Dani Bancroft

aspergillosis aspergillus mathias eu pet mri

News and Trends 23 Feb 2016

This new Antibody-based Imaging Technology could help fight Deadly Fungal Infections

It is estimated that up to 200,000 people globally die from fungal lung infections (Aspergillosis). Now, the EU-funded Fp7 MATHIAS project has developed an imaging technique to help doctors fight this huge killer of patients with weakened immune systems. The new test involves attaching radioactively labelled antibodies to the infecting structures formed by the fungus Aspergillus fumigatus. These fungal spores […]

February 23, 2016 - 3 minutesmins - By Dani Bancroft

vitadx bladder Cancer diagnostics cnrs

News and Trends 22 Feb 2016

Making Bladder Cancer Cells Glow earns French Biotech €1.5M

VitaDX (France), is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research. This simple urine sample analysis has attracted over €1.5M in preparation for clinical trials and a global market launch. The technology operated by VitaDX is the result of a research collaboration between the Institute of Molecular […]

February 22, 2016 - 3 minutesmins - By Dani Bancroft

ADVERTISEMENT